EAU22 recommendations
The 37th Annual EAU Congress (EAU22) will be held in Amsterdam, the Netherlands on 1-4 July 2022.
EAU22 offers a more concentrated scientific programme than usual, with a full four-day congress. Our editorial board has selected some sessions and abstracts that they highly recommend:
Friday 1 July
Plenary Session 01: Challenges in renal cancer
- Small renal mass
- Locally advanced tumour
- Oligometastatic disease
- Metastatic disease
- State-of-the-art lecture: Patient engagement is a potential blockbuster treatment that urologists should prescribe for their cancer patients, M. Jewett, Toronto (CA)
Abstract Session 12: Localised kidney cancer: Alternative treatments in special situations
- A0205 The detrimental effect of frailty status on renal function recovery after partial nephrectomy – long-term results from a prospective surgical cohort, G. Rosiello, Bacoli (IT)
- A0222 Decision-making and management strategies for patients with bilateral synchronous non-metastatic renal masses: Insights from a multi-centre European dataset, R. Campi, Florence (IT)
Saturday 2 July
Abstract Session 18: Trials in Progress
- A0326 Protective effect of LCZ696 on kidney function after partial nephrectomy, J.I. Brignone, Aalborg (DK)
ESU Course 18: Practical aspects of cancer pathology for urologists. The 2022 WHO novelties
- Kidney tumours with the 2022, WHO eyes, F. Algaba, Barcelona (ES)
Monday 4 July
Plenary Session 07: Liquid biomarkers in 2022 and beyond: Ready for prime time?
- Rapid-fire debate Liquid biomarkers in kidney cancer
Abstract Session 53: Optimising treatment in locally advanced disease
- A1004 Application of the KEYNOTE-564 trial results to real life population: Which patients with advanced kidney cancer should receive adjuvant pembrolizumab
- A1005 Adjuvant therapy after surgical resection of nonmetastatic renal-cell carcinoma: One size does not fit all, Z-E. Khene, Rennes (FR)
- A1008 Pembrolizumab outperforms tyrosine kinase inhibitors in the adjuvant therapy of patients with high-risk renal cell carcinoma: A systematic review and network meta-analysis, E. Laukhtina, Vienna (AT)
Patient information session: Kidney cancer session
- How communication between HCPs and (kidney) cancer patients can be improved, to be confirmed
To see the whole scientific programme, visit EAU22 congress website.
